methylselenic acid has been researched along with Bone Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YC; Das, A; Mastro, AM; Prabhu, KS | 1 |
| Aryee, DN; Kauer, M; Kofler, R; Kontny, U; Kovar, H; Meier, A; Niedan, S; Pötschger, U; Schwentner, R | 1 |
| Chen, YC; Gandhi, UH; Mastro, AM; Novinger, LJ; Prabhu, KS; Sosnoski, DM | 1 |
| Chen, S; Chen, Y; Lin, D; Ma, RZ; Pei, Z; Wu, X; Yang, X; Zhang, Y | 1 |
4 other study(ies) available for methylselenic acid and Bone Neoplasms
| Article | Year |
|---|---|
Dietary selenium supplementation modifies breast tumor growth and metastasis.
Topics: Animals; Blotting, Western; Bone Neoplasms; Dietary Supplements; Female; Flow Cytometry; Interferon-gamma; Interleukin-2; Interleukin-6; Kidney Neoplasms; Lung Neoplasms; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Organoselenium Compounds; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Selenomethionine; Sodium Selenite; Tumor Cells, Cultured | 2013 |
Suppression of FOXO1 is responsible for a growth regulatory repressive transcriptional sub-signature of EWS-FLI1 in Ewing sarcoma.
Topics: Animals; Antineoplastic Agents; Base Sequence; Binding Sites; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Consensus Sequence; Cyclin-Dependent Kinase 2; Forkhead Box Protein O1; Forkhead Box Protein O3; Forkhead Transcription Factors; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Mice; Oncogene Proteins, Fusion; Organoselenium Compounds; Phosphorylation; Promoter Regions, Genetic; Protein Processing, Post-Translational; Protein Transport; Proto-Oncogene Protein c-fli-1; Proto-Oncogene Proteins c-akt; RNA-Binding Protein EWS; Sarcoma, Ewing; Transcription, Genetic; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |
Selenium modifies the osteoblast inflammatory stress response to bone metastatic breast cancer.
Topics: Animals; Bone Neoplasms; Breast Neoplasms; Cell Communication; Cell Differentiation; Cell Line, Tumor; Chemokine CCL2; Culture Media, Conditioned; Cyclooxygenase 2; Female; Humans; Inflammation; Interleukin-6; Mice; NF-kappa B; Nitric Oxide Synthase Type II; Organoselenium Compounds; Osteoblasts; Selenium | 2009 |
Methylseleninic acid restricts tumor growth in nude mice model of metastatic breast cancer probably via inhibiting angiopoietin-2.
Topics: Angiopoietin-2; Animals; Blotting, Western; Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Female; Gene Expression; Humans; Immunohistochemistry; Mice; Mice, Nude; Organoselenium Compounds; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Signal Transduction; Tumor Burden; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2012 |